source
- Meet Aletta: The first FDA approved robotic blood draw deviceThe FDA has approved Vitestro’s Aletta as the first standalone robotic device in the U.S. designed to draw blood without the need for hands-on human help.Fierce Biotech · 8h ago↗ source
- Novo Nordisk leads early in oral obesity market, but analysts doubt lasting advantageNovo Nordisk's oral formulation of Wegovy generated DKK 3.22 billion (about $496 million) in revenue in the second quarter of 2026, far outpacing Eli Lilly's newly approved oral weight‑loss pill Fo…
- Tolerance Bio secures up to $260 M for thymus‑targeting fusion protein, moves into Phase 2 trials